Quantcast
Home > Quotes > VBIV

VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) Quote & Summary Data

VBIV 
$2.91
*  
0.03
1.04%
Get VBIV Alerts
*Delayed - data as of Jul. 17, 2018 11:36 ET  -  Find a broker to begin trading VBIV now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    VBIV Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 2.90 / $ 2.92
1 Year Target
10
Today's High / Low
$ 2.92 / $ 2.78
Share Volume
47,456
50 Day Avg. Daily Volume
358,912
Previous Close
$ 2.88
52 Week High / Low
$ 5.10 / $ 2.56
Market Cap
186,867,766
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.32

Intraday Chart

Shares Traded

Share Volume:
47,456
50 Day Avg. Daily Volume:
358,912

Trading Range

The current last sale of $2.91 is 13.67% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 2.92 $ 5.10
 Low: $ 2.78 $ 2.56

Company Description (as filed with the SEC)

VBI is a pharmaceutical company developing novel technologies that seek to expand vaccine protection in large, underserved markets. We have developed an eVLP vaccine platform that allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. Using this proprietary technology platform, we have undertaken specific projects related to human cytomegalovirus ("CMV") and other antigens. In 2015, the Company prepared several batches of vaccine for a toxicology trial, in compliance with the Good Manufacturing Practices ("GMP") enforced by the US Food and Drug Administration ("FDA"), for a Phase I clinical trial and for other regulatory purposes. In April 2015, we began the toxicology trial for our human CMV vaccine.  ... More ...  

Risk Grade

Where does VBIV fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 2.85
Open Date:
Jul. 17, 2018
Close Price:
$ 2.88
Close Date:
Jul. 16, 2018

Consensus Recommendation

Analyst Info